Myriad Genetics Inc (MYGN)
Number of days of payables
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 22.12 | 20.37 | 22.15 | 28.74 | 27.20 | 20.70 | 18.48 | 20.09 | 16.99 | 25.65 | 21.60 | 20.77 | 42.43 | 20.32 | 31.84 | 34.15 | 30.60 | 23.32 | 29.34 | 25.65 | |
Number of days of payables | days | 16.50 | 17.92 | 16.48 | 12.70 | 13.42 | 17.63 | 19.75 | 18.16 | 21.48 | 14.23 | 16.90 | 17.57 | 8.60 | 17.96 | 11.46 | 10.69 | 11.93 | 15.65 | 12.44 | 14.23 |
September 30, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 22.12
= 16.50
The number of days of payables for Myriad Genetics Inc has fluctuated over the past few quarters, ranging from as low as 8.60 days to as high as 21.48 days. The trend appears to be somewhat volatile, with no clear pattern emerging from the data. The significant variances in the number of days of payables could indicate various factors affecting the company's payment practices, such as changes in supplier terms or the efficiency of the company's accounts payable process. It would be advisable for stakeholders to monitor this metric closely to understand the impact on the company's cash flow and working capital management.
Peer comparison
Sep 30, 2024